Literature DB >> 223921

A human neoplastic hematopoietic cell line producing a fibroblast type of interferon.

I Larsson, E Lundgren, K Nilsson, O Strannegard.   

Abstract

1301 is a subline of the EBV-genome negative T leukemia line CCRF-CEM. IF was induced by Sendai virus. By use of neutralizing antisera and by studies of some physical properties it could be shown that IF was of the fibroblast type. This was confirmed by its antiviral effect on heterologous cell lines.

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 223921

Source DB:  PubMed          Journal:  Dev Biol Stand        ISSN： 0301-5149


  5 in total

1.  Clinical-scale in vitro expansion preserves biological characteristics of cardiac atrial appendage stem cells.

Authors:  S Windmolders; L Willems; A Daniëls; L Linsen; Y Fanton; M Hendrikx; R Koninckx; J-L Rummens; K Hensen
Journal:  Cell Prolif       Date:  2015-01-29       Impact factor: 6.831

2.  Enhanced telomere shortening in transformed lymphoblasts from patients with X linked dyskeratosis.

Authors:  L Montanaro; P L Tazzari; M Derenzini
Journal:  J Clin Pathol       Date:  2003-08       Impact factor: 3.411

3.  Spontaneous production of gamma interferon and induced production of beta interferon by human T-lymphoblastoid cell lines.

Authors:  A G Morris; J Morser; A Meager
Journal:  Infect Immun       Date:  1982-02       Impact factor: 3.441

4.  Accelerated telomere shortening precedes development of therapy-related myelodysplasia or acute myelogenous leukemia after autologous transplantation for lymphoma.

Authors:  Sujata Chakraborty; Can-Lan Sun; Liton Francisco; Melanie Sabado; Liang Li; Karen L Chang; Stephen Forman; Smita Bhatia; Ravi Bhatia
Journal:  J Clin Oncol       Date:  2009-01-05       Impact factor: 44.544

5.  The production of interferon-alpha and -beta by cloned human lymphoblastoid cells. Brief report.

Authors:  S Hoshino; J Imanishi; H Matsuoka; T Kishida
Journal:  Arch Virol       Date:  1983       Impact factor: 2.574
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.